Centessa Pharmaceuticals
Mandy Sterkel, Ph.D., currently serves as the Senior Director of Clinical Development for the Orexin program at Centessa Pharmaceuticals, a position held since September 2024. Prior experience includes a series of roles at Jazz Pharmaceuticals from July 2016 to August 2024, culminating as Director of Clinical Development in Neuroscience. Notable past positions also include Postdoctoral Research Scholar at Stanford University School of Medicine and various graduate research and teaching roles at West Virginia University. Education includes a Ph.D. and Master's Degree in Psychology, as well as a Bachelor's Degree in Animal Sciences, all obtained from West Virginia University. Mandy Sterkel possesses extensive expertise in clinical trial development, regulatory processes, grant writing, and scientific communication.
This person is not in any teams
This person is not in any offices
Centessa Pharmaceuticals
1 followers
Centessa Pharmaceuticals Limited is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams. Each program is developed by an Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.